成年人全血γ-干扰素释放试验检测结果与年龄的相关性
Correlation of QuantiFERON-TB gold in-tube test result with age of adults

DOI: 10.6040/j.issn.1671-7554.0.2015.493

Keywords: 结核分枝杆菌,全血γ-干扰素释放试验,年龄,
Mycobacterium,QuantiFERON-TB gold in-tube test,Age

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Weddle G, Hamilton M, Potthoff D, et al. QuantiFERON-TB gold in-tube testing for tuberculosis in healthcare professionals[J]. Lab Med, 2014, 45(3):207-210.
[2]	Menzies D, Pai M, Comstock G. Meta-analysis:new tests for the diagnosis of latent tuberculosis infection:areas of uncertainty and recommendations for research[J]. Ann Intern Med, 2007, 146(5):340-354.
[3]	Tebruegge M, De Graaf H, Sukhtankar P, et al. Extremes of age are associated with indeterminate QuantiFERON-TB gold assay results[J]. J Clin Microbiol, 2014, 52(7):2694-2697.
[4]	Dorman SE, Belknap R, Graviss EA, et al. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States[J]. Am J Respir Crit Care Med, 2014, 189(1):77-87.
[5]	Markova R, Drenska R, Minchev P, et al. Association of age with the level of response in the QuantiFERON-TB Gold In-Tube assay for children with active tuberculosis[J]. New Microbiol, 2011, 34(1):81-85.
[6]	Yoshiyama T, Harada N, Higuchi K, et al. Use of the QuantiFERON<sup>？</sup>-TB gold in tube test for screening TB contacts and predictive value for active TB[J]. Infect Dis(Lond), 2015, 47(8):542-549.
[7]	Connell TG, Tebruegge M, Ritz N, et al. Indeterminate interferon-γ release assay results in children[J]. Pediatr Infect Dis J, 2010, 29(3):285-286.
[8]	Rose MV, Kimaro G, Nissen TN, et al. QuantiFERON<sup>？</sup>-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting[J]. PloS One, 2012, 7(7):e37851. doi:37810.31371/journal.pone.0037851.
[9]	Banfield S, Pascoe E, Thambiran A, et al. Factors associated with the performance of a blood-based interferon-γ release assay in diagnosing tuberculosis[J]. PloS One, 2012, 7(6):e38556. doi:38510.31371/journal.pone.0038556.
[10]	Cattamanchi A, Smith R, Steingart KR, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals a systematic review and meta-analysis[J]. J Acquir Immune Defic Syndr, 2011, 56(3):230-238.
[11]	Cho K, Cho E, Kwon S, et al. Factors associated with indeterminate and false negative results of QuantiFERON-TB Gold In-Tube test in active tuberculosis[J]. Tuberc Respir Dis(Seoul), 2012, 72(5):416-425.
[12]	Perez-Velez CM, Marais BJ. Tuberculosis in children[J]. N Engl J Med, 2012, 367(4):348-361.
[13]	Andersen P, Munk M, Pollock J, et al. Specific immune-based diagnosis of tuberculosis[J]. Lancet, 2000, 356(9235):1099-1104.
[14]	Stebler A, Iseli P, Muhlemann K, et al. Whole-blood interferon-gamma release assay for baseline tuberculosis screening of healthcare workers at a Swiss university hospital[J]. Infection Control, 2008, 29(7):681-683.
[15]	Bui D-HP, Cruz AT, Graviss EA. Indeterminate QuantiFERON-TB gold in-tube assay results in children:possible association with procedural specimen collection[J]. Pediatr Infect Dis J, 2014, 33(2):220-222.
[16]	Bartalesi F, Vicidomini S, Goletti D, et al. QuantiFERON-TB gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases[J]. Eur Respir J, 2009, 33(3):586-593.
[17]	Ellis R, Hatherill M, Tait D, et al. Innovative clinical trial designs to rationalize TB vaccine development[J]. Tuberculosis(Edinb), 2015, 95(3):352-357.

Full-Text